Author:
Vilhelmsson Andreas,Svensson Tommy,Meeuwisse Anna,Carlsten Anders
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference47 articles.
1. The EU Pharmacovogilance System. [
http://ec.europa.eu/health/files/eudralex/vol-1/reg_2010_1235/reg_2010_1235_en.pdf
]
2. Borg J-J, Aislaitner G, Pirozynski M, Mifsud S: Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to?. Drug Saf. 2011, 34 (3): 187-197. 10.2165/11586620-000000000-00000.
3. World Health Organization: Safety of Medicines-a Guide to Detecting and Reporting Adverse Drug. Reaction - Why Health Professionals Need to Take Action. 2002, Geneva
4. World Health Organization: The Safety of Medicines in Public Health Programmes: pharmacovigilance An Essential Tool. 2006, Geneva
5. Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC: Evaluation of the patient reporting of adverse drug reactions to the UK ‘yellow card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011, 15 (20):
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献